Vidas SARS-COV-2 antibody serology tests receive EUA
Aug. 14, 2020—BioMérieux received emergency use authorization by the U.S. Food and Drug Administration for its Vidas SARS-COV-2 IgM and Vidas SARS-COV-2 IgG serology tests.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Siemens gets EUA for semiquantitative antibody test
Aug. 12, 2020—Siemens Healthineers received FDA emergency use authorization for the SARS-CoV-2 IgG antibody test. It is the.first antibody test authorized with a semiquantitative detection claim.
Sysmex to distribute, service Siemens Clinitek Novus
Aug. 11, 2020–Sysmex America announced an exclusive agreement with Siemens Healthineers that grants North American rights to distribute and service Siemens Clinitek Novus Automated Urine Analyzer for hospital and reference laboratory use.
Roche launches Cobas Prime Pre-analytical System
Aug. 6, 2020—Roche launched its Cobas Prime Pre-analytical System, designed to automate common preanalytic steps performed in a molecular diagnostics laboratory, including vortexing, decapping, aliquoting, barcode labeling, reagent addition, and heating.
Diazyme, Maccura launch COVID-19 test
Aug. 5, 2020—Diazyme announced a partnership with Maccura Biotechnology (USA) and launched an FDA EUA approved SARS-COV-2 RT-PCR diagnostics test.
Sysmex America releases Caresphere Workflow Solution
Aug. 4, 2020—Sysmex America announced the availability of its clinical software application, Caresphere Workflow Solution, a Hitrust CSF–certified, cloud-based software solution that is designed to enable sophisticated test result workflow optimization for laboratories to meet increasing demands, streamline decision-making, and reduce risk.
Alpha-Tec launches SARS-CoV-2, HPV controls
July 31, 2020—Alpha-Tec Systems has partnered with Microbix to provide whole-genome molecular REDx control products
FDA approves Ventana HER2 Dual ISH test as CDx
July 30, 2020—Roche announced U.S. Food and Drug Administration approval of the Ventana HER2 Dual ISH DNA Probe Cocktail assay
Bio SB launches Fast Mohs PolyDetector Plus for IHC
July 29, 2020—Bio SB launched its Fast Mohs PolyDetector Plus Detection System, a highly sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry detection system
FDA approves expanded version of BD HPV assay
July 28, 2020—Becton Dickinson received approval for a premarket approval supplement from the FDA for an expanded version of its BD Onclarity HPV Assay.